[{"NetIncomeLoss_1_Q1_USD":-22901000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":32502000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1_Q1_USD":16.08,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":1605.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":2000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_1_Q1_USD":0.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q1_USD":6213000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":1280000.0,"AssetsCurrent_0_Q1_USD":157804000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":2535000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":6008000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q1_USD":18380000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":57000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":35153000.0,"CommonStocksIncludingAdditionalPaidInCapital_0_Q1_USD":339976000.0,"CommonStockSharesIssued_0_Q1_shares":33030000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":45086000.0,"Assets_0_Q1_USD":163550000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-6000.0,"ShareBasedCompensation_1_Q1_USD":3406000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":2152000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":1244000.0,"InterestReceivableCurrent_0_Q1_USD":85000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":19000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"ResearchAndDevelopmentExpense_1_Q1_USD":17584000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":14.67,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":5486000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-271000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":57000.0,"DeferredCompensationLiabilityClassifiedNoncurrent_0_Q1_USD":18000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_1_Q1_USD":0.0,"RestrictedCash_0_Q1_USD":500000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q1_USD":150700000.0,"OtherAssetsCurrent_0_Q1_USD":912000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q1_USD":14.67,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_1_Q1_USD":0.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":105579000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":3788000.0,"Liabilities_0_Q1_USD":14070000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-6000.0,"OperatingLeaseLiability_0_Q1_USD":4648000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q1_USD":11.48,"DepreciationAndAmortization_1_Q1_USD":224000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":5334000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":33012000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-22907000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":11.01,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":838000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":871000.0,"RestrictedCashNoncurrent_0_Q1_USD":500000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q1_shares":5996.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":2782000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":21000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":3406000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-20067000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":1208000.0,"LiabilitiesCurrent_0_Q1_USD":10264000.0,"NonoperatingIncomeExpense_1_Q1_USD":17000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":106079000.0,"CommonStockSharesOutstanding_0_Q1_shares":33017000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":7139000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q1_USD":18380000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_0_Q1_Security":0.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":13.0,"NumberOfOperatingSegments_1_Q1_Segment":1.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_1_Q1_USD":0.0,"PrepaidInsurance_0_Q1_USD":436000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":21000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q1_USD":14090000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":3094000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":57000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":12492000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-190515000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q1_shares":2172.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":487000.0,"CommonStockSharesAuthorized_0_Q1_shares":200000000.0,"OperatingIncomeLoss_1_Q1_USD":-22918000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q1_USD":100000.0,"InvestmentIncomeInterest_1_Q1_USD":30000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q1_pure":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":15.29,"PreferredStockValue_0_Q1_USD":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":4.47,"LiabilitiesAndStockholdersEquity_0_Q1_USD":163550000.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":3406000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q1_USD":41200000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":5876000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":860000.0,"OperatingExpenses_1_Q1_USD":22918000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.69,"OtherLiabilitiesCurrent_0_Q1_USD":860000.0,"StockholdersEquity_0_Q1_USD":149480000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":116000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":45067000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-83000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":5996.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":883000.0,"ShortTermInvestments_0_Q1_USD":45086000.0,"Ticker":"CRNX","CIK":"1658247","name":"CRINETICS PHARMACEUTICALS, INC.","OfficialName":"Crinetics Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1104302360.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210506"}]